Brief: CG Oncology Reports 2024 Year End Financial Results And Provides Business Updates
28/03/2025 11:52
March 28 (Reuters) - CG Oncology Inc CGON.O: CG ONCOLOGY REPORTS 2024 YEAR END FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES CG ONCOLOGY INC: QTRLY LOSS PER SHARE $0.46 Source text: ID:nGNXbvgS0k Further company coverage: CGON.O ((Reuters.Briefs@thomsonreuters.com;))